UWKI yields 200000000.00% · JNJ yields 2.13%● Live data
📍 UWKI pulled ahead of the other in Year 1
Combined, UWKI + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of UWKI + JNJ for your $10,000?
uWink Inc. Del develops and operates digital media entertainment and hospitality software. It also develops and operates an interactive restaurant concept under the name uWink that incorporates and showcases its entertainment and hospitality software. It offers Hospitality ordering, a touch-based user interface that allows users to self-order various food and drink through touch screen terminals; Self check in/checkout software, which enables users to self-check in and checkout at the table using a credit card or pre-paid debit card; and Multi-player game platform, which allows users to play digital games in real time. The company also provides uWink Game Library that features single and multi-player short-form, casual, and social video games; Micro-transaction game play monetization software for game credit purchasing, tracking, and redemption; Media display system, which exhibits revolving imagery for restaurants to change its look and feel. In addition, it licenses SNAP!, a countertop video game platform; and Bear Shop, an entertainment vending platform to third party manufacturers. Its restaurant menu features a selection of appetizers, entrees, pizzas, burgers, salads, pastas, and desserts. The company was incorporated in 1999 and is based in Van Nuys, California.
Full UWKI Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.